Provided by Tiger Trade Technology Pte. Ltd.

Credit Suisse Holdings

2,469.81
+26.231.07%
Number of Gainers:54
Number of Losers:41
Number of Flat:2
PE:- -
High:2,480.54
Open:2,443.77
Low:2,443.77
Close:2,443.58
Volume:1.44B
Turnover:296.38B
Market Cap:51.71T
Float Cap:48.39T

Loading ...

Merck Says Experimental Skin Disease Drug Meets Main Goal in Mid-Stage Study

Reuters
·
Sep 30

Honeywell Declares Q4 2026 Dividend of R$ 2.4172447320 Per Unit, Payable Dec. 15

Reuters
·
Sep 30

Hewlett Packard Enterprise Secures $1.2 Billion Vultr Order for AMD Helios Systems; Shares Rise Pre-Bell

MT Newswires Live
·
Sep 30

Merck Says Tulisokibart Hits Primary Endpoint in Phase 2b Hidradenitis Suppurativa Trial

Reuters
·
Sep 30

Merck & Co - Study Meets Primary Endpoint Hiscr50 at Week 16 for High- and Medium-Dose Tulisokibart

THOMSON REUTERS
·
Sep 30

Merck's Tulisokibart Met Primary and Key Secondary Endpoints in Phase 2B Study in Patients with Moderate to Severe Hidradenitis Suppurativa (Hs)

THOMSON REUTERS
·
Sep 30

Merck & Co - no Serious or Opportunistic Infections Observed in Study

THOMSON REUTERS
·
Sep 30

Amazon Price Target Raised to $360.00/Share from $335.00 by Rosenblatt

Dow Jones
·
Sep 30

Apple Set to Launch Smart Home Hub with Voice Recognition and Recipe Lookup, Plus Personalized Interface Switching

Deep News
·
Sep 30

TSMC Reportedly Weighs Texas Expansion as Second Major U.S. Chip Hub

Stock News
·
Sep 30

Analysts’ Top Technology Picks: Braze (BRZE), Accenture (ACN)

TIPRANKS
·
Sep 30

KIDZ AI Plans Autonomous Fleet Operations Strategy Tied to Potential 500 Tesla Robotaxi Acquisition

Reuters
·
Sep 30

Honeywell Technologies Selected for About $300 Million Kenya Refinery Work

MT Newswires Live
·
Sep 30

Lilly Says Phase 3b ADtouch Trial Shows Ebglyss Beats Placebo in Hand and Foot Atopic Dermatitis Skin Clearance at Week 16

Reuters
·
Sep 30

IBM Study Shows 62% of CFOs Take on Enterprise AI Strategy Leadership

Reuters
·
Sep 30

Bank of America Private Bank Study Shows 89% of Wealthy Americans Give to Charity in 2025

Reuters
·
Sep 30

ISG Says Brazil Public Agencies Accelerate Digital Modernization Under Fiscal Pressure

Reuters
·
Sep 30

Eli Lilly - 77% of Ebglyss Patients Reported Satisfaction with Hand Clearance at Week 16

THOMSON REUTERS
·
Sep 30

Eli Lilly - Ebglyss Monotherapy Meets Primary and Secondary Endpoints at Week 16 in Phase 3B Adtouch Study

THOMSON REUTERS
·
Sep 30

New Phase 3B Data Show Lilly's Ebglyss (Lebrikizumab-Lbkz) Delivered Significant and Rapid Improvements in Skin Clearance, Itch, Pain, and Patient Satisfaction in People with Moderate-to-Severe Hand and Foot Atopic Dermatitis

THOMSON REUTERS
·
Sep 30